Dr. Susan Chang, MD, is a highly respected neuro-oncologist and professor of neurological surgery at the University of California, San Francisco (UCSF). As Director of the UCSF Division of Neuro-Oncology, Dr. Chang is internationally recognized for her expertise in treating brain tumors, with a focus on gliomas and other primary central nervous system tumors. Her work is at the forefront of advancing personalized therapies for brain cancer patients, integrating cutting-edge clinical research with compassionate patient care. Dr. Chang’s research centers on developing innovative treatment strategies that improve survival and quality of life for brain tumor patients. She leads several clinical trials aimed at understanding the molecular and genetic underpinnings of brain tumors, helping to develop targeted therapies and immunotherapies that provide more effective and less invasive treatment options. She has published extensively in leading medical journals and is a sought-after speaker at international conferences on neuro-oncology.
After earning her medical degree from McGill University in Canada, Dr. Chang completed her residency in internal medicine at Toronto General Hospital and a fellowship in neuro-oncology at UCSF. She is a key leader in numerous professional organizations, including the Society for Neuro-Oncology (SNO), where she has served in various leadership roles, and the National Cancer Institute (NCI), where she contributes to shaping future research in neuro-oncology. In addition to her clinical and research achievements, Dr. Chang is deeply committed to mentoring the next generation of neuro-oncologists and researchers. Her dedication to improving patient outcomes, coupled with her leadership in advancing the field of brain cancer treatment, has earned her widespread recognition as a leader in neuro-oncology and a champion for innovation in cancer care.